Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact

Citations to this article

Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver.
J Reichen, M Le
J Reichen, M Le
Published August 1, 1986
Citation Information: J Clin Invest. 1986;78(2):448-455. https://doi.org/10.1172/JCI112596.
View: Text | PDF
Research Article Article has an altmetric score of 6

Verapamil favorably influences hepatic microvascular exchange and function in rats with cirrhosis of the liver.

  • Text
  • PDF
Abstract

The effect of the calcium channel blocking agent, verapamil, on microcirculatory patterns and hepatic function was investigated in the perfused liver of cirrhotic rats. Compared with controls, cirrhotic livers had higher vascular resistance, increased intrahepatic shunting, and smaller extravascular albumin space and larger extravascular sucrose space, as determined by a multiple-indicator dilution technique. Hepatic function, estimated by determining propranolol and antipyrine extraction, was markedly reduced in cirrhotic livers. Portal pressure was then reduced 25% either pharmacologically by verapamil or hydrodynamically by lowering inflow. Verapamil decreased vascular resistance by 22%. This was associated with a 38% reduction in intrahepatic shunting and a 62% increase in extravascular albumin space. Hydrodynamically lowering pressure had no or adverse effects. The verapamil-induced improvement in microcirculatory characteristics was associated with a significant improvement in oxygen consumption (+21%) and antipyrine clearance (+20%). We conclude that the microvascular distortions of liver cirrhosis in the rat are partially reversible by vasodilators like verapamil.

Authors

J Reichen, M Le

×

Total citations by year

Year: 2021 2015 2012 2011 2010 2008 2007 2006 2005 2004 2003 2002 2001 2000 1999 1998 1997 1996 1995 1994 1993 1992 1991 1990 1989 1988 1987 Total
Citations: 1 1 2 3 1 5 3 2 5 4 5 3 2 1 3 5 5 4 3 10 7 8 3 8 7 4 7 112
Citation information
This citation data is accumulated from CrossRef, which receives citation information from participating publishers, including this journal. Not all publishers participate in CrossRef, so this information is not comprehensive. Additionally, data may not reflect the most current citations to this article, and the data may differ from citation information available from other sources (for example, Google Scholar, Web of Science, and Scopus).

Citations to this article (112)

Title and authors Publication Year
Randomised clinical study: acute effects of metformin versus placebo on portal pressure in patients with cirrhosis and portal hypertension
N Rittig, NK Aagaard, GE Villadsen, TD Sandahl, N Jessen, H Grønbæk, J George
Alimentary Pharmacology & Therapeutics 2021
Textbook of Pediatric Gastroenterology, Hepatology and Nutrition
S Guandalini, A Dhawan, D Branski
2015
Blumgart's Surgery of the Liver, Pancreas and Biliary Tract
CV Cott, R Zuckerman, WS Helton
Blumgart's Surgery of the Liver, Pancreas and Biliary Tract 2012
The Influence of Old Age and Poloxamer-407 on the Hepatic Disposition of Diazepam in the Isolated Perfused Rat Liver
SJ Mitchell, A Huizer-Pajkos, VC Cogger, AJ McLachlan, DG Couteur, B Jones, R de Cabo, SN Hilmer
Pharmacology 2012
Age-Related Pseudocapillarization of the Liver Sinusoidal Endothelium Impairs the Hepatic Clearance of Acetaminophen in Rats
SJ Mitchell, A Huizer-Pajkos, VC Cogger, AJ McLachlan, DG le Couteur, B Jones, R Cabo, SN Hilmer
The Journals of Gerontology Series A: Biological Sciences and Medical Sciences 2011
Praxis der Viszeralchirurgie. Gastroenterologische Chirurgie
JR Siewert, M Rothmund, V Schumpelick
2011
Portale Hypertension
Bauer J, Clavien PA, Dutkowski P, Gantert WA, Lurje G, Müllhaupt B, Renner EL, Schmeding M, Selzner M, von Flüe M, Sieber C
2011
Nitric oxide induced sinusoidal relaxation after a propranolol priming dose in the perfused rat liver reduces propranolol availability on subsequent dosing
X Liu, Y Zou, AM Khlentzos, Y Yang, J Nikolovski, M Weiss, MS Roberts
Clinical and Experimental Pharmacology and Physiology 2010
Effect of cold ischemia–warm reperfusion on the cirrhotic rat liver
PM Huet, L Giroux, M Laurens, D Crenesse
Liver Transplantation 2008
Regulation of Sinusoidal Perfusion in Portal Hypertension
H Reynaert, D Urbain, A Geerts
The Anatomical Record: Advances in Integrative Anatomy and Evolutionary Biology 2008
Portal Hypertension III: Proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies
M Pinzani
Portal Hypertension III: Proceedings of the Third Baverno International Consensus Workshop on Definitions, Methodology and Therapeutic Strategies 2008
Effect of early bosentan administration on the development of esophageal varices in cirrhotic rats: experimental study in Wistar rats
S Rafailidis, K Ballas, K Psarras, T Pavlidis, E Emoniotou, R Papamichali, G Kalodimos, G Marakis, A Sakadamis, G Koukoulis
Journal of Gastroenterology 2008
EFFECTS OF LIVER FIBROSIS ON VERAPAMIL PHARMACOKINETICS IN RATS
M Chen, D Xu, XL Hu, H Wang
Clinical and Experimental Pharmacology and Physiology 2008
Protective effect of verapamil on multiple hepatotoxic factors-induced liver fibrosis in rats
D Xu, Y Wu, ZX Liao, H Wang
Pharmacological Research 2007
Influence of somatostatin and octreotide on liver microcirculation in an experimental mouse model of cirrhosis studied by intravital fluorescence microscopy
E Vanheule, AM Geerts, H Reynaert, HV Vlierberghe, A Geerts, MD Vos, I Colle
Liver International 2007
Praxis der Viszeralchirurgie
V Schumpelick, JR Siewert, M Rothmund
2007
Effect of verapamil on nitric oxide synthase in a portal vein-ligated rat model: Role of prostaglandin
CS Lay
World journal of gastroenterology : WJG 2006
Sensitivity to endothelin-1 is decreased in isolated livers of endothelial constitutive nitric oxide synthase knockout mice
AD Gottardi, E Biecker, A Koshy, D Bohler, S Shaw, H Sägesser, J Reichen
Comparative hepatology 2006
Portal Hypertension
RJ Groszmann, JG Abraldes
Journal of Clinical Gastroenterology 2005
Microcirculation of the aging liver: Is getting old like having cirrhosis?
PM Huet, JP Villeneuve
Hepatology 2005
Variceal Bleeding: Pharmacological Therapy
J Bosch, JG Abraldes
Digestive Diseases 2005
The Management of Portal Hypertension
JG Abraldes, B Angermayr, J Bosch
Clinics in Liver Disease 2005
Neutral endopeptidase (EC 3.4.24.11) in cirrhotic liver: a new target to treat portal hypertension?
G Sansoè, M Aragno, R Mastrocola, F Restivo, G Mengozzi, A Smedile, F Rosina, O Danni, M Parola, M Rizzetto
Journal of Hepatology 2005
Reversible factors in portal hypertension
M Pinzani, F Vizzutti
Journal of Gastroenterology and Hepatology 2004
Sphingosine 1-phosphate enhances portal pressure in isolated perfused liver via S1P2 with Rho activation
H Ikeda, K Nagashima, M Yanase, T Tomiya, M Arai, Y Inoue, K Tejima, T Nishikawa, N Watanabe, M Omata, K Fujiwara
Biochemical and Biophysical Research Communications 2004
Que doit-on faire pour prévenir les hémorragies par rupture de varices oesophagiennes ?
C Bureau
Gastroentérologie Clinique et Biologique 2004
Portal Hypertension in the 21st Century
RJ Groszmann, J Bosch
2004
Current pharmacotherapy in the management of cirrhosis: focus on the hyperdynamic circulation
RB Vaughan, JP Chin-Dusting
Expert Opinion on Pharmacotherapy 2003
Pharmacological rationale for the use of somatostatin and analogues in portal hypertension
H Reynaert, A Geerts
Alimentary Pharmacology & Therapeutics 2003
Hepatic and systemic haemodynamic changes after MARS in patients with acute on chronic liver failure
MV Catalina, J Barrio, F Anaya, M Salcedo, D Rincón, G Clemente, R Bañares
Liver International 2003
Current management of portal hypertension
J Bosch, JG Abraldes, R Groszmann
Journal of Hepatology 2003
Nitric oxide and portal hypertension: a nitric oxide-releasing derivative of ursodeoxycholic acid that selectively releases nitric oxide in the liver
S Fiorucci, E Antonelli, A Morelli
Digestive and liver disease : official journal of the Italian Society of Gastroenterology and the Italian Association for the Study of the Liver 2003
In vivo gene transfer of endothelial nitric oxide synthase decreases portal pressure in anaesthetised carbon tetrachloride cirrhotic rats
MV de Casteele, A Omasta, S Janssens, T Roskams, V Desmet, F Nevens, J Fevery
Gut 2002
Hepatic stellate cells: role in microcirculation and pathophysiology of portal hypertension
H Reynaert, MG Thompson, T Thomas, A Geerts
Gut 2002
The paradox of nitric oxide in cirrhosis and portal hypertension: Too much, not enough
R Wiest
Hepatology 2002
Effect of release-controlled nifedipine on portal hemodynamics in cirrhotic patients
Q Chengyong, L Dongxing, Z Juren, F Lina, W Zhaohai, Z Guoquan, J Tao
Chinese Journal of Digestive Diseases 2001
Treatment of Variceal Bleeding
PJ McKiernan
Gastrointestinal Endoscopy Clinics of North America 2001
Liver fibrosis
M Pinzani
Springer Seminars in Immunopathology 2000
Myofibroblasts in the cirrhotic rat liver reflect hepatic remodeling and correlate with fibrosis and sinusoidal capillarization
A Zimmermann, D Zhao, J Reichen
Journal of Hepatology 1999
The Role of the Sinusoidal Endothelium in Liver Function
J Reichen
Physiology (Bethesda, Md.) 1999
Prostaglandin E1 infusion and functional hepatic flow in control subjects and in patients with cirrhosis
A Fabbri, D Magalotti, M Brizi, G Bianchi, M Zoli, G Marchesini
Digestive Diseases and Sciences 1999
Effects of Tetramethylpyrazine on Portal Hypertensive Rats
FC Chang, KJ Chen, JG Lin, CY Hong, YT Huang
Journal of Pharmacy and Pharmacology 1998
Beneficial Hemodynamic Effects of Dipyridamole on Portal Circulation in Cirrhosis
G Sansoe, A Ferrari, P D'Alimonte, T Trenti, P Zoboli, R Romagnoli, E Villa, F Manenti
The American Journal of Gastroenterology 1998
Effects of Systemic Prostaglandin E1 on Splanchnic and Peripheral Haemodynamics in Control Subjects and in Patients with Cirrhosis
A Fabbri, D Magalotti, G Marchesini, M Brizi, G Bianchi, M Zoli
Prostaglandins & Other Lipid Mediators 1998
The effect of endothelin and its antagonist Bosentan on hemodynamics and microvascular exchange in cirrhotic rat liver
J Reichen, AL Gerbes, MA Steiner, H Sägesser, M Clozel
Journal of Hepatology 1998
Effects of systemic prostaglandin e on hepatic amino acid-nitrogen metabolism in patients with cirrhosis
A Fabbri, G Bianchi, M Brizi, E Bugianesi, D Magalotti, M Zoli, G Marchesini
Hepatology 1998
Haemodynamic effects of chronic tetrandrine treatment in portal hypertensive rats
YT Huang, YR Cheng, HC Lin, CF Chen, CY Hong
Journal of Gastroenterology and Hepatology 1997
Portal Hypotensive Effects of Tetrandrine and Verapamil in Portal Hypertensive Rats
TB Liu, HC Lin, YT Huang, CM Sun, CY Hong
Journal of Pharmacy and Pharmacology 1997
5 Pharmacological prevention of variceal bleeding. New developments
JC García-Pagán, J Bosch
Bailliere's Clinical Gastroenterology 1997
Targeting Naproxen to Non-Parenchymal Liver Cells Protects Against Endotoxin Induced Liver Damage
C Lebbe, J Reichen, E Wartna, H Sägesser, K Poelstra, D Meijer
Journal of Drug Targeting 1997
Hemodynamic effects of acute tetrandrine and terlipressin administration on portal hypertensive rats
YT Huang, JF Tsai, HC Lin, CF Chen, CY Yong
Canadian Journal of Physiology and Pharmacology 1997
Effects of calcium antagonists on hepatic and systemic hemodynamics in awake portal hypertensive rats
M Nagasawa, T Kawasaki, T Yoshimi
Journal of Gastroenterology 1996
Effect of verapamil on renal haemodynamics in a portal hypertensive rat model
CS Lay, MC Yang, SL Wu, YT Tsai, KL Wu, S Chien
Journal of Gastroenterology and Hepatology 1996
Effect of verapamil on portal and splanchnic hemodynamics in patients with advanced posthepatitic cirrhosis using duplex Doppler ultrasound
H Dinç, S Kaplcloglu, N Cihanyurdu, G Çan, M Ünal, L Topkaya, HR Gümele
European Journal of Radiology 1996
Phagocytic function and metabolite production in thioacetamide-induced liver cirrhosis: a comparative study in perfused livers and cultured Kupffer cells
H Petermann, S Heymann, S Vogl, R Dargel
Journal of Hepatology 1996
Solvent isotope effect on bile formation in the rat
C Elsing, A Hirlinger, EL Renner, BH Lauterburg, PJ Meier, J Reichen
Biochemical Journal 1995
Continuous prazosin administration in cirrhotic patients: Effects on portal hemodynamics and on liver and renal function
A Albillos, JL Lledó, I Rossi, M Pérez-Páramo, MJ Tabuenca, R Bañares, J Iborra, A Garrido, P Escartín, J Bosch
Gastroenterology 1995
Clinical Pharmacokinetic and Pharmacodynamic Considerations in Patients with Liver Disease: An Update
DJ Morgan, AJ McLean
Clinical Pharmacokinetics 1995
Ursodeoxycholate-induced hypercholeresis in cirrhotic rats: Further evidence for cholehepatic shunting
C Elsing, H Sägesser, JÜ Reichen
Hepatology 1994
Augmentation of portal blood flow improves function of human cirrhotic liver
JE Cardoso, C Gautreau, PR Jeyaraj, D Patrzalek, B Cherruau, M Vaubourdolle, C Legendre, T Wroblewski, D Houssin
Hepatology 1994
Endothelin-1 induces direct constriction of hepatic sinusoids
V Shah, G García-Cardeña, WC Sessa, RJ Groszmann
The American journal of physiology 1994
Nicardipine increases hepatic blood flow and the hepatic clearance of indocyanine green in patients with cirrhosis
JC García-Pagán, F Feu, A Luca, M Fernández, P Pizcueta, J Bosch, J Rodés
Journal of Hepatology 1994
Effect of verapamil on hepatic reperfusion injury after prolonged ischemia in pigs
M Uchida, Y Takemoto, N Nagasue, DK Dhar, H Kohno, T Nakamura
Journal of Hepatology 1994
Portal pumping: a new perspective for treatment of variceal hemorrhage and liver failure in end-stage cirrhosis?
JE Cardoso, ME Meteini, Y Calmus, M Vaubourdolle, D Houssin
Journal of Hepatology 1994
Endothelin-1 induces direct constriction of hepatic sinusoids
V Shah, G García-Cardeña, WC Sessa, RJ Groszmann
The American journal of physiology 1994
Liver function improvement following increased portal blood flow in cirrhotic rats
JE Cardoso, L Giroux, I Kassissia, D Houssin, N Habib, PM Huet
Gastroenterology 1994
Pharmacological treatment of portal hypertension: Hemodynamic effects and prevention of bleeding
D Lebrec
Pharmacology & Therapeutics 1994
Assessment of Liver Metabolic Function: Clinical Implications
J Brockmöller, I Roots
Clinical Pharmacokinetics 1994
Clearance by the liver in cirrhosis. I. Relationship between propranolol metabolismin vitro and its extraction by the perfused liver in the rat
D Fenyves, L Gariépy, JP Villeneuve
Hepatology 1993
Handling of epidermal growth factor and number of epidermal growth factor receptors are changed in aged male rats
U Marti
Hepatology 1993
Medikamentöse Behandlung der portalen hypertonie
EL Renner
European Surgery 1993
Effect of verapamil on hepatic ischemia/reperfusion injury
HJ Stein, MM Oosthuizen, RA Hinder, H Lamprechts
The American Journal of Surgery 1993
Decreased hepatic glucose production in rats with carbon tetrachloride-induced cirrhosis
S Krähenbühl, J Reichen
Journal of Hepatology 1993
Metabolism of antipyrine in vivo in two rat models of liver cirrhosis ita relationship to intrinsic clearance in vitro and microsomal membrane lipid composition
JT Buters, T Zysset, J Reichen
Biochemical Pharmacology 1993
Effects of vasopressin and nicardipine on hemodynamics and liver function in patients with cirrhosis: comparison with vasopressin alone
T Iwao, A Toyonaga, M Ikegami, K Oho, M Sumino, M Sakaki, H Shigemori, M Nakayama, E Sasaki, K Tanikawa
Journal of Hepatology 1993
Effects of alcohol on liver haemodynamics in the presence and absence of liver disease
H Orrego, FJ Carmichael
Journal of Gastroenterology and Hepatology 1992
Hepatic accumulation of lysosomes and defective transcytotic vesicular pathways in cirrhotic rat liver
JF Dufour, P Gehr, J Reichen
Hepatology 1992
Abnormal lipid composition of microsomes from cirrhotic rat liver—does it contribute to decreased microsomal function?
J Reichen, JT Buters, Z Sojcic, FJ Roos
Experientia 1992
Stereological and functional analysis of liver mitochondria from rats with secondary biliary cirrhosis: Impaired mitochondrial metabolism and increased mitochondrial content per hepatocyte
S Krähenbühl, S Krähenbühl-Glauser, J Stucki, P Gehr, J Reichen
Hepatology 1992
Review article: the pathophysiology and pharmacological treatment of portal hypertension
RD Grose, PC Hayes
Alimentary Pharmacology & Therapeutics 1992
Hemodynamic effects of terbutaline, a β2-adrenoceptor agonist, in conscious rats with secondary biliary cirrhosis
JL Poo, A Braillon, A Hadengue, C Gaudin, D Lebrec
Hepatology 1992
Prophylaxis of first variceal bleeding
G Kleber, H Ansari, T Sauerbruch
Bailliere's Clinical Gastroenterology 1992
PHARMACOLOGIC TREATMENT OF PORTAL HYPERTENSION
F Rodríguez-Pérez, RJ Groszmann
Gastroenterology Clinics of North America 1992
Therapeutic implications of impaired hepatic oxygen diffusion in chronic liver disease
DJ Morgan, AJ McLean
Hepatology 1991
Differential effect of biliary and micronodular cirrhosis on oxidative drug metabolism
FJ Roos, T Zysset, J Reichen
Biochemical Pharmacology 1991
Clinical Pharmacokinetics in Patients with Liver Disease:
AJ McLean, DJ Morgan
Clinical Pharmacokinetics 1991
Liver function and pharmacological considerations in pathogenesis and treatment of portal hypertension
JÜ Reichen
Hepatology 1990
Mitochondrial structure and function in CCl4-induced cirrhosis in the rat
S Krählenbühl, J Reichen, A Zimmermann, P Gehr, J Stucki
Hepatology 1990
Lack of effect of verapamil and isosorbide dinitrate on the hepatic clearance of indocyanine green in cirrhosis
C Merkel, M Bolognesi, P Angeli, GF Finucci, P Amodio, S Bellon, A Gatta
British Journal of Clinical Pharmacology 1990
Effect of verapamil on splanchnic haemodynamics in a portal hypertensive rat model
CS Lay, YT Tsai, CM Yang, HI Chen, S Simchon, S Chien, KJ Lo
Journal of Gastroenterology and Hepatology 1990
Doxorubicin for unresectable hepatocellular carcinoma. A prospective study on the addition of verapamil
EC Lai, TK Choi, CH Cheng, FP Mok, ST Fan, ES Tan, J Wong
Cancer 1990
Hepatic circulation: Potential for therapeutic intervention
F Ballet
Pharmacology & Therapeutics 1990
Taking the Tension out of the Portal System: An Approach to the Management of Portal Hypertension in the 1990s
PM Mathuna, D Westaby, R Williams
Scandinavian Journal of Gastroenterology 1990
Ritanserin decreases portal pressure in conscious and unrestrained cirrhotic rats
R Mastai, L Giroux, M Semret, PM Huet
Gastroenterology 1990
The role of calcium channels and serotonin (5-HT2) receptors for tumour cell lodgement in the liver
G Skolnik, U Bagge, G Blomqvist, L Djärv, H Ahlman
Clinical & Experimental Metastasis 1989
Correlation of caffeine elimination and child's classification in liver cirrhosis
A Holstege, M Staiger, K Haag, W Gerok
Klinische Wochenschrift 1989
Effect of vasodilators on hepatic microcirculation in cirrhosis: A study in the isolated perfused rat liver
P Marteau, F Ballet, O Chazouillères, Y Chrétien, C Rey, D Petit, R Poupon
Hepatology 1989
Vasodilator therapy of portal hypertension: Focus on the liver
AT Blei
Hepatology 1989
Combination of ketanserin and verapamil or propranolol in patients with alcoholic cirrhosis: Search for an additive effect
A Hadengue, R Moreau, R Cerini, A Koshy, SS Lee, D Lebrec
Hepatology 1989
Verapamil has no effect on porto-hepatic pressure gradient, hepatic blood flow and elimination function of the liver in patients with liver cirrhosis
JP Vinel, JP Caucanas, JM Combis, P Cales, JJ Voigt, JP Pascal
Journal of Hepatology 1989
Current Perspectives in Hepatology
LB Seeff, JH Lewis
1989
Role of the hepatic artery in canalicular bile formation by the perfused rat liver. A multiple indicator dilution study
J Reichen
Journal of Clinical Investigation 1988
Determinants of hepatic function in liver cirrhosis in the rat. Multivariate analysis
J Reichen, B Egger, N Ohara, TB Zeltner, T Zysset, A Zimmermann
Journal of Clinical Investigation 1988
Effects of verapamil on hepatic and systemic hemodynamics and liver function in patients with cirrhosis and portal hypertension
M Navasa, J Bosch, J Reichen, C Bru, R Mastai, T Zysset, G Silva, J Chesta, J Rodés
Hepatology 1988
The calcium-channel blocker, verapamil, does not improve portal pressure in patients with alcoholic cirrhosis
C Merkel, A Gatta, M Bolognesi, R Padrini, GF Finucci, P Angeli, A Ruol
British Journal of Clinical Pharmacology 1988
Microcirculatory abnormalities in liver diseases
JP Villeneuve, PM Huet
Hepatology 1987
Drugs for portal hypertension
D Lebrec
Journal of Gastroenterology and Hepatology 1987
The effect of calcium channel blockade with nifedipine on splanchnic and systemic haemodynamics in cirrhosis
P Macmathuna, T O'reilly, D Kelleher, M Barry, J Feely, PW Keeling
Alimentary Pharmacology & Therapeutics 1987
Lack of effects of Nifedipine on hepatic hemodynamics in patients with HBsAg-positive cirrhosis
CS Lay, YT Tsai, CW Kong, FY Lee, SD Lee, KJ Lo, BN Chiang, KY Chen
Liver 1987
The effect of drugs on the portal circulation
J Reichen, D Lebrec
Journal of Hepatology 1987
Pathophysiology of the hepatorenal syndrome and potential for therapy
M Levy
The American Journal of Cardiology 1987
Aminopyrine N-demethylation by rats with liver cirrhosis
J Reichen, B Arts, U Schafroth, A Zimmermann, TB Zeltner, T Zysset
Gastroenterology 1987

← Previous 1 2 3 4 5 Next →

Advertisement

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts

Referenced in 3 patents
5 readers on Mendeley
See more details